Differential effect of genetic variants of Na+-taurocholate co-transporting polypeptide (NTCP) and organic anion-transporting polypeptide 1B1 (OATP1B1) on the uptake of HMG-CoA reductase inhibitors

• Published in: Xenobiotica Vol. 41; no. 1; pp. 24 - 34
• Main Authors: Choi, Min-Koo, Shin, Ho Jung, Choi, Young-Lim, Deng, Jian-Wei, Shin, Jae-Gook, Song, Im-Sook
• Format: Journal Article
• Language: English
• Published: England Informa Healthcare 01.01.2011; Taylor & Francis
• Subjects: Animals; Atorvastatin Calcium; Estrone - analogs & derivatives; Estrone - metabolism; Fluorobenzenes - metabolism; Genetic Variation; Heptanoic Acids - metabolism; Hydroxymethylglutaryl-CoA Reductase Inhibitors - metabolism; NTCP; OATP1B1; Oocytes - metabolism; Organic Anion Transporters - genetics; Organic Anion Transporters, Sodium-Dependent - genetics; Pyrimidines - metabolism; Pyrroles - metabolism; Quinolines - metabolism; Rosuvastatin Calcium; Solute Carrier Organic Anion Transporter Family Member 1b1; statins; Substrate specificity; Sulfonamides - metabolism; Symporters - genetics; Taurocholic Acid - metabolism; Xenopus laevis
• ISSN: 0049-8254; 1366-5928
• DOI: 10.3109/00498254.2010.523736

The purpose of this study was to investigate the effect of genetic variations in organic anion-transporting polypeptide 1B1 (OATP1B1) and Na+/taurocholate co-transporting polypeptide (NTCP) on the uptake of various statins having different affinities for these transporters. The functional activities and simultaneous expression of NTCP and OATP1B1 were confirmed by the uptake of taurocholate and estrone-3-sulphate as representative substrates for NTCP and OATP1B1, respectively, and by an immunofluorescence analysis. The substrate specificities of NTCP and OATP1B1 for statins and the effects of genetic variations on the uptake of rosuvastatin, pitavastatin, and atorvastatin were measured. Based on the Km values and intrinsic clearances of the three statins, pitavastatin was taken up more efficiently than rosuvastatin and atorvastatin by OATP1B1. Consequently, the cellular accumulation of pitavastatin was modulated according to the genetic variation of OATP1B1 (OATP1B1*15), rather than NTCP*2. In contrast, NTCP*2 displayed greater transport of atorvastatin and rosuvastatin, compared with NTCP wild type. Thus, the measurements of decreased rosuvastatin and atorvastatin transport by OATP1B1*15 were confounded by the presence of NTCP and its genetic variant, NTCP*2. In conclusion, the functional consequences of genetic variants of NTCP and OATP1B1 may be different for various statins, depending on the substrate specificity of the OATP1B1 and NTCP transporters.